LATe Cerclage in High-risk Pregnancies (LATCH)
Thomas Jefferson University · NCT06036446
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–50 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 329
- US sites recruiting
- 2
- Study start
- November 10, 2023
- Record last updated
- May 29, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to determine whether cervical cerclage reduces the risk of preterm birth in patients with a short transvaginal ultrasound (TVU) cervical length (CL) ≤25mm between 24 0/7-26 6/7 weeks.
Being studied: Cervical cerclage; Vaginal Suppository Progesterone
Conditions: Premature Birth
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 18-50 years old, pregnant, assigned female at birth
- Singleton pregnancy
- TVU CL ≤25mm between 24 0/7 - 26 6/7 weeks of gestation
Exclusion Criteria
- Initial multifetal gestation with subsequent multifetal pregnancy reduction, or selective fetal termination performed >14 weeks, or cotwin pregnancy loss diagnosed >14 weeks
- Cerclage in situ
- Preterm labor, defined as painful regular uterine contractions and change in cervical dilation
- PPROM
- Active vaginal bleeding
- Suspected intraamniotic infection
- Major fetal structural abnormality or chromosomal disorder
- Placenta previa or accreta
- Other contraindication to cerclage placement
- Participation in another clinical trial related to preterm birth prevention, cerclage, or progesterone
Recruiting US locations
Atrium Health Carolinas Medical Center
Charlotte, NC 28204
Site contact: Lorene Temming, MD, MSCI · 704-448-0305 · Lorene.Temming@advocatehealth.org
Thomas Jefferson University
Philadelphia, PA 19107
Site contact: Moti Gulersen, MD, MSc · 215-955-5000 · moti.gulersen@jefferson.edu
Study contacts (from the official record)
- Moti Gulersen, MD, MSc · 215-955-5000 · moti.gulersen@jefferson.edu
- Vincenzo Berghella, MD · 215-955-5000 · vincenzo.berghella@jefferson.edu
Similar studies in North Carolina
All pregnancy studies in North Carolina →- RecruitingHealthy volunteersEarly Phase 1
Uric Acid, Klotho and Salt Sensitivity in Young Adults Born Preterm
Wake Forest University Health Sciences
- Location
- Winston-Salem, NC
- Eligibility basics
- Ages 22–33
- RecruitingHealthy volunteersPhase 3
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
Pfizer
- Location
- Durham, NC + 76 other US sites
- Eligibility basics
- Ages 0 mo+
- RecruitingHealthy volunteersPhase 3
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Pfizer
- Location
- Durham, NC + 111 other US sites
- Eligibility basics
- Ages 0 mo–49
- RecruitingHealthy volunteers
Non-Invasive Preeclampsia Screening and Biobank
Sequenom, Inc.
- Location
- Winston-Salem, NC + 15 other US sites
- Eligibility basics
- Ages 18+ · Women only